Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.

Fan T, Chen C, Guo H, Xu J, Zhang J, Zhu X, Yang Y, Zhou Z, Li L, Huang Y.

Eur J Pharm Biopharm. 2014 Oct;88(2):518-28. doi: 10.1016/j.ejpb.2014.06.011. Epub 2014 Jun 24.

PMID:
24968819
2.

Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.

Jin Y, Song Y, Zhu X, Zhou D, Chen C, Zhang Z, Huang Y.

Biomaterials. 2012 Feb;33(5):1573-82. doi: 10.1016/j.biomaterials.2011.10.075. Epub 2011 Nov 16.

PMID:
22093292
3.

Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids.

Chen C, Fan T, Jin Y, Zhou Z, Yang Y, Zhu X, Zhang ZR, Zhang Q, Huang Y.

Nanomedicine (Lond). 2013 Jul;8(7):1085-100. doi: 10.2217/nnm.12.141. Epub 2012 Oct 17.

PMID:
23075315
4.

Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.

Yuan H, Chen CY, Chai GH, Du YZ, Hu FQ.

Mol Pharm. 2013 May 6;10(5):1865-73. doi: 10.1021/mp300649z. Epub 2013 Apr 5.

PMID:
23495754
5.

Mechanism study of cellular uptake and tight junction opening mediated by goblet cell-specific trimethyl chitosan nanoparticles.

Zhang J, Zhu X, Jin Y, Shan W, Huang Y.

Mol Pharm. 2014 May 5;11(5):1520-32. doi: 10.1021/mp400685v. Epub 2014 Apr 11.

PMID:
24673570
6.

Solid lipid nanoparticles modified with stearic acid-octaarginine for oral administration of insulin.

Zhang ZH, Zhang YL, Zhou JP, Lv HX.

Int J Nanomedicine. 2012;7:3333-9. doi: 10.2147/IJN.S31711. Epub 2012 Jul 2.

7.

Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.

Zhou X, Zhang X, Ye Y, Zhang T, Wang H, Ma Z, Wu B.

Int J Pharm. 2015 Feb 20;479(2):391-8. doi: 10.1016/j.ijpharm.2014.12.068. Epub 2014 Dec 30.

PMID:
25556104
8.

Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.

Ke Z, Guo H, Zhu X, Jin Y, Huang Y.

J Pharm Pharm Sci. 2015;18(2):155-70.

9.

N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.

Chen G, Svirskis D, Lu W, Ying M, Huang Y, Wen J.

J Control Release. 2018 May 10;277:142-153. doi: 10.1016/j.jconrel.2018.03.013. Epub 2018 Mar 13.

PMID:
29548985
10.

Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.

Shi LL, Lu J, Cao Y, Liu JY, Zhang XX, Zhang H, Cui JH, Cao QR.

Drug Dev Ind Pharm. 2017 May;43(5):839-846. doi: 10.1080/03639045.2016.1220571. Epub 2016 Aug 21.

PMID:
27487431
11.

The glucose-lowering potential of exenatide delivered orally via goblet cell-targeting nanoparticles.

Li X, Wang C, Liang R, Sun F, Shi Y, Wang A, Liu W, Sun K, Li Y.

Pharm Res. 2015 Mar;32(3):1017-27. doi: 10.1007/s11095-014-1513-1. Epub 2014 Oct 1.

PMID:
25270570
12.

Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.

Paliwal R, Rai S, Vaidya B, Khatri K, Goyal AK, Mishra N, Mehta A, Vyas SP.

Nanomedicine. 2009 Jun;5(2):184-91. doi: 10.1016/j.nano.2008.08.003. Epub 2008 Dec 17.

PMID:
19095502
13.

Transport Mechanisms of Solid Lipid Nanoparticles across Caco-2 Cell Monolayers and their Related Cytotoxicology.

Chai GH, Xu Y, Chen SQ, Cheng B, Hu FQ, You J, Du YZ, Yuan H.

ACS Appl Mater Interfaces. 2016 Mar 9;8(9):5929-40. doi: 10.1021/acsami.6b00821. Epub 2016 Feb 23.

PMID:
26860241
14.

Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.

Zhang N, Ping Q, Huang G, Xu W, Cheng Y, Han X.

Int J Pharm. 2006 Dec 11;327(1-2):153-9. Epub 2006 Jul 21.

PMID:
16935443
15.

Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.

Li H, Zhao X, Ma Y, Zhai G, Li L, Lou H.

J Control Release. 2009 Feb 10;133(3):238-44. doi: 10.1016/j.jconrel.2008.10.002. Epub 2008 Oct 12.

PMID:
18951932
16.

A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway.

Mudhakir D, Akita H, Tan E, Harashima H.

J Control Release. 2008 Jan 22;125(2):164-73. Epub 2007 Nov 4.

PMID:
18054812
17.

Biomimetic solid lipid nanoparticles for oral bioavailability enhancement of low molecular weight heparin and its lipid conjugates: in vitro and in vivo evaluation.

Paliwal R, Paliwal SR, Agrawal GP, Vyas SP.

Mol Pharm. 2011 Aug 1;8(4):1314-21. doi: 10.1021/mp200109m. Epub 2011 Jun 2.

PMID:
21598996
18.

The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats.

Zhang Z, Bu H, Gao Z, Huang Y, Gao F, Li Y.

Int J Pharm. 2010 Jul 15;394(1-2):147-53. doi: 10.1016/j.ijpharm.2010.04.039. Epub 2010 May 8.

PMID:
20435111
19.

Pharmacokinetics, tissue distribution and relative bioavailability of geniposide-solid lipid nanoparticles following oral administration.

Wang F, Cao J, Hao J, Liu K.

J Microencapsul. 2014;31(4):382-9. doi: 10.3109/02652048.2013.863396. Epub 2014 Apr 3.

PMID:
24697172
20.

Transport of stearic acid-based solid lipid nanoparticles (SLNs) into human epithelial cells.

Shah RM, Rajasekaran D, Ludford-Menting M, Eldridge DS, Palombo EA, Harding IH.

Colloids Surf B Biointerfaces. 2016 Apr 1;140:204-212. doi: 10.1016/j.colsurfb.2015.12.029. Epub 2015 Dec 28.

PMID:
26764103

Supplemental Content

Support Center